Yunfei Yuan - Search Results

Year	Number of Results
2002	2
2004	3
2005	4
2006	3
2007	2
2008	7
2009	3
2010	11
2011	9
2012	14
2013	16
2014	14
2015	16
2016	17
2017	18
2018	23
2019	9
2020	18
2021	18
2022	16
2023	12
2024	5

1

Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

Wang DS, Ren C, Li SS, Fong WP, Wu XJ, Xiao J, Li BK, Zheng Y, Ding PR, Chen G, Qiu MZ, Wang ZQ, Wang FH, Luo HY, Wang F, Wang XZ, Wang LY, Xie DJ, Chen T, Li LR, Lu ZH, Zhai XH, Liu TS, Yuan Y, Chen JQ, Tan Q, Pan ZZ, Wan DS, Zhang R, Yuan YF, Xu RH, Li YH. Wang DS, et al. PLoS Med. 2024 May 10;21(5):e1004389. doi: 10.1371/journal.pmed.1004389. eCollection 2024 May. PLoS Med. 2024. PMID: 38728364 Free PMC article. Clinical Trial.

2

Regorafenib with immunotherapy versus regorafenib alone as second-line treatment for hepatocellular carcinoma: A multicenter real-world study.

Qiao L, He W, Wang G, Chen H, Huang F, Zhang B, Qiu Y, Liu S, Huang Z, Yuan Y, Qiu J, Yuan Y, Li B. Qiao L, et al. Among authors: yuan y. Cancer Med. 2024 May;13(9):e7236. doi: 10.1002/cam4.7236. Cancer Med. 2024. PMID: 38716585 Free PMC article.

3

Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma.

Shi Y, Li K, Yuan Y, Wang C, Yang Z, Zuo D, Niu Y, Qiu J, Li B, Yuan Y, He W. Shi Y, et al. Among authors: yuan y. Cancer Cell Int. 2024 Apr 16;24(1):138. doi: 10.1186/s12935-024-03307-3. Cancer Cell Int. 2024. PMID: 38627760 Free PMC article.

4

Watch-and-Wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma：a propensity score-matching comparative study.

Li B, Wang C, He W, Qiu J, Zheng Y, Zou R, Lin Z, Shi Y, Yuan Y, Zhang R, Zhang C, Chen M, Lau WY, Yuan Y. Li B, et al. Among authors: yuan y. Int J Surg. 2024 Feb 8. doi: 10.1097/JS9.0000000000001155. Online ahead of print. Int J Surg. 2024. PMID: 38329081

5

RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1.

Qiu Z, Wang C, Huang P, Yuan Y, Shi Y, Lin Z, Huang Z, Zuo D, Qiu J, He W, Shen J, Niu Y, Yuan Y, Li B. Qiu Z, et al. Among authors: yuan y. Clin Transl Med. 2023 Dec;13(12):e1511. doi: 10.1002/ctm2.1511. Clin Transl Med. 2023. PMID: 38093528 Free PMC article.

6

TSPO is a novel biomarker for prognosis that regulates cell proliferation through influencing mitochondrial functions in HCC.

Pan JH, Kang YQ, Li Q, Xing W, Chen YH, Yan Y, Luo DX, Qiu Y, Yuan YF, Zeng WA, Chen DT. Pan JH, et al. Heliyon. 2023 Nov 24;9(12):e22590. doi: 10.1016/j.heliyon.2023.e22590. eCollection 2023 Dec. Heliyon. 2023. PMID: 38090016 Free PMC article.

7

METTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition.

Bi F, Qiu Y, Wu Z, Liu S, Zuo D, Huang Z, Li B, Yuan Y, Niu Y, Qiu J. Bi F, et al. Among authors: yuan y. Cell Death Discov. 2023 Nov 28;9(1):428. doi: 10.1038/s41420-023-01723-4. Cell Death Discov. 2023. PMID: 38017014 Free PMC article.

8

Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.

Wang C, Li K, Huang Z, Yuan Y, He W, Zheng Y, Zou R, Li B, Yuan Y, Qiu J. Wang C, et al. Among authors: yuan y. J Cancer Res Clin Oncol. 2023 Nov;149(16):15113-15125. doi: 10.1007/s00432-023-05286-w. Epub 2023 Aug 26. J Cancer Res Clin Oncol. 2023. PMID: 37632543

9

Early recurrence of hepatocellular carcinoma in patients after ablation and resection: A propensity score analysis.

Wu Z, Zeng Y, Yuan Y, Shi Y, Qiu J, Li B, Yuan Y, He W. Wu Z, et al. Among authors: yuan y. Am J Surg. 2024 Feb;228:94-101. doi: 10.1016/j.amjsurg.2023.08.002. Epub 2023 Aug 3. Am J Surg. 2024. PMID: 37580221

10

Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma.

Li K, Niu Y, Li K, Zhong C, Qiu Z, Yuan Y, Shi Y, Lin Z, Huang Z, Zuo D, Yuan Y, Li B. Li K, et al. Among authors: yuan y. J Clin Transl Hepatol. 2023 Oct 28;11(5):1094-1105. doi: 10.14218/JCTH.2022.00401. Epub 2023 Apr 21. J Clin Transl Hepatol. 2023. PMID: 37577214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

219 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year